Skip to content
value.today

Integrative Diagnostics, Inc.

🇺🇸 Seattle, Washington, USABiotechnologyFounded 2009
Total raised
$45 M
3 rounds on record
Latest round
$6 M
Nov 2016
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Integrative Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2016$6 MNo. 3$2 to $10 million

Integrative Diagnostics, Inc.: Raise no. 3, Nov 2016

Investors in this round

6 investors had bought by the notice of Dec 8, 2016: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Albert Luderer · Executive Officer, Director
  • Douglas Sanders · Executive Officer
  • Paul Kearney · Executive Officer
  • Stephen Davis · Executive Officer
  • Arnold Oronsky · Director
  • David Barker · Director
  • Michael Liang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Douglas Sanders, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 8, 2016. Read the notice at the SEC.

equitySEC
Apr 2014$32 MNo. 2$10 to $50 million

Integrative Diagnostics, Inc.: Raise no. 2, Apr 2014

Investors in this round

6 investors had bought by the notice of May 7, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $32 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Albert Luderer · Executive Officer, Director
  • James Garner · Executive Officer
  • John Bencich · Executive Officer
  • Kenneth Fang · Executive Officer
  • Paul Kearney · Executive Officer
  • Arnold Oronsky · Director
  • David Barker · Director
  • Greg Critchfield · Director
  • James Heath · Director
  • Jay Moyes · Director
  • Leroy Hood · Director
  • Michael Liang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Bencich, Chief Financial Officer. Source: SEC Form D, newest notice filed May 7, 2014. Read the notice at the SEC.

equitySEC
Sep 2009$8 MNo. 1$2 to $10 million

Integrative Diagnostics, Inc.: Raise no. 1, Sep 2009

Investors in this round

4 investors had bought by the notice of Sep 15, 2009: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $30 M offered; $23 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Kearney · Executive Officer, Director
  • David Galas · Director
  • James Heath · Director
  • Leroy Hood · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds from the offering will be used for general working capital.”

Signed by Paul Kearney, President. Source: SEC Form D, newest notice filed Sep 15, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Integrative Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2016).

    SEC Form D · Dec 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2016

That is all the official record says: Integrative Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Integrative Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Integrative Diagnostics, Inc.
NameRoleNamed in
Albert LudererExecutive officerDec 2016
Douglas SandersExecutive officerDec 2016
Paul KearneyExecutive officerDec 2016
Stephen DavisExecutive officerDec 2016
James GarnerExecutive officerMay 2014
John BencichExecutive officerMay 2014
Kenneth FangExecutive officerMay 2014
Albert LudererDirectorDec 2016
Arnold OronskyDirectorDec 2016
David BarkerDirectorDec 2016
Michael LiangDirectorDec 2016
Greg CritchfieldDirectorMay 2014
James HeathDirectorMay 2014
Jay MoyesDirectorMay 2014
Leroy HoodDirectorMay 2014
David GalasDirectorSep 2009
Paul KearneyDirectorSep 2009